Store sealed lyophilized peptide vials frozen at −20 °C or colder, tightly closed, dry and protected from light. Before opening, let the vial warm to room temperature in a desiccator. Once dissolved, aliquot the solution and keep aliquots frozen [1][3].
What lyophilization is and why peptides are supplied dry
Lyophilization (freeze-drying) removes water from a frozen sample under vacuum. It runs in three stages: freezing, primary drying, where ice is removed by sublimation, and secondary drying, where most of the remaining unfrozen water is removed by desorption [10]. The result is a dry solid, often a fluffy cake or film at the bottom of the vial.
Peptides are supplied this way because water drives most of their chemical degradation, including hydrolysis and deamidation [9]. In the dry state these reactions slow considerably. Suppliers advise against keeping peptides in solution for long periods, and lyophilized peptides can usually be shipped at ambient temperature before going into frozen storage on receipt [1][6].
Storing sealed vials
- Temperature: Bachem recommends storage below −15 °C for maximum stability [2]. Thermo Fisher recommends −20 °C or −80 °C on receipt [6]. Sigma-Aldrich describes −20 °C as suitable for shorter periods and −80 °C as preferable for longer storage [3].
- Short term: Refrigeration at about 4 °C is acceptable for short periods for many peptides [1].
- Moisture: Keep vials tightly capped. Moisture reduces long-term stability [3].
- Light and oxygen: Protect vials from bright light and limit exposure of the solid to air [3].
- Freeze–thaw: Avoid repeatedly cycling even the lyophilized material in and out of the freezer; take what you need and return the vial promptly [3].
Sequences containing Asn, Gln, Met, Cys or Trp have shorter shelf lives, so give them the coldest, driest storage available [1].
Opening a cold vial without moisture uptake
Lyophilized peptides are often hygroscopic. If a cold vial is opened in room air, water condenses on the solid. Absorbed water lowers the effective peptide content of what you weigh and can reduce stability [1][2].
- Move the sealed vial from the freezer into a desiccator.
- Let it reach room temperature before opening [1][2].
- Weigh out the amount needed quickly.
- Optionally flush the headspace with dry nitrogen or argon to displace air [3][6].
- Recap tightly and return the vial to frozen storage.
Counter-ions and net peptide content
The powder in a vial is not 100% peptide. Synthetic peptides are typically isolated as salts with counter-ions such as trifluoroacetate (TFA) or acetate, and the solid also holds some residual water. Bachem notes that a peptide with more than 95% HPLC purity may still have a peptide content of about 70–90% of the solid [2].
TFA salts are common because TFA is used for cleavage in solid-phase synthesis and as an ion-pairing agent in reversed-phase HPLC purification. Residual TFA adds mass, which can cause weighing errors. It has also been reported to affect some cell-based assays. Exchange to chloride or acetate salts is possible [8].
- HPLC purity is not peptide content. Purity describes the share of the target sequence among peptide species. Net peptide content describes how much of the weighed solid is peptide.
- When preparing solutions of defined molar concentration, correct the gross weight using the net peptide content reported for that lot [2].
- Note the salt form on your records. A TFA salt and an acetate salt of the same sequence differ in molecular weight and may behave differently in cell work [8].
Choosing a solvent
Solubility depends mainly on the sequence’s charge and hydrophobicity. To estimate net charge at pH 7, assign −1 to each Asp, Glu and the free C-terminus, and +1 to each Lys, Arg and the free N-terminus. His counts +1 only below about pH 6 [4]. Then pick a starting solvent:
- Basic peptides (net positive): Try water first. If needed, add a small amount of dilute acetic acid, then dilute with water or buffer [1][4][6].
- Acidic peptides (net negative): Add a small amount of dilute ammonium bicarbonate or ammonia, then dilute [1][4][6]. Avoid basic conditions for Cys-containing peptides, because thiols oxidize readily above pH 7 [1][6].
- Hydrophobic or neutral peptides: Dissolve in a minimal volume of DMSO, DMF or acetonitrile, then add the solution dropwise to stirred aqueous buffer. Turbidity means the solubility limit has been reached [1][4][6]. Keep the final organic solvent concentration compatible with your assay [1].
- Cys- or Met-containing peptides: Avoid DMSO, because sequences containing Cys or Met are unstable in it [4]. For hydrophobic sequences that contain Cys or Met, other organic solvents listed for hydrophobic peptides, such as DMF or acetonitrile, are sometimes used instead [4].
Test-dissolving and sonication
- Weigh a small portion of the peptide and test the chosen solvent on it before committing the whole lot [4][6].
- Start with a solvent that can be removed by lyophilization, so the material can be recovered if it fails [4].
- Dissolve fully in the initial solvent before diluting into buffer [4].
- If particles remain, sonicate briefly in a water bath. Avoid prolonged sonication, which heats the sample [1][4].
- Check the result. A cloudy, gelled or particulate solution is a suspension, not a solution, and needs a different solvent [4].
Sterile filtration for cell culture work
For cell culture experiments, prepare stocks in sterile water or sterile dilute acetic acid where applicable [3]. Pass the solution through a 0.22 µm sterile filter. Choose a low-binding membrane such as PES or PVDF, since binding to the filter depends on membrane surface charge, hydrophobicity and contact time [7].
Stability in solution
Peptides in solution have a limited shelf life. Sigma-Aldrich describes many peptide solutions as stable for up to about a week at 4 °C [3], and Thermo Fisher advises using dissolved peptide within a week [6]. For anything longer:
- Divide the stock into single-use aliquots [3][5].
- Freeze aliquots at −20 °C or colder; −80 °C is preferable for longer holds [3].
- Thaw one aliquot per experiment and do not refreeze it [3][5].
- Where the assay allows, use sterile buffers at pH 5–6 [3].
- Avoid prolonged exposure to pH above 8. If high pH is unavoidable, keep the solution chilled [3][5].
- For oxidation-prone sequences, use degassed or oxygen-free solvents and minimize headspace air [1][6].
Residues and common degradation pathways
Reviewing the sequence before you dissolve it helps you anticipate problems [5][9].
| Residue or motif | Pathway | Conditions that favor it | Handling response |
|---|---|---|---|
| Cys | Oxidation to disulfides (intra- or inter-chain) | pH above 7, dissolved oxygen | Degassed acidic buffers; avoid DMSO; DTT or TCEP can reverse disulfides [1][5] |
| Met | Oxidation to sulfoxide, then sulfone | Oxygen, peroxides, light | Avoid DMSO; oxygen-free solvents; inert gas headspace [4][5][9] |
| Trp | Oxidation | Oxygen, light | Protect from light; oxygen-free solvents [1][3] |
| Asn, Gln (especially Asn-Gly, Gln-Gly) | Deamidation via cyclic imide to Asp/isoAsp or Glu | Neutral to basic pH, time in solution | Minimize time in solution; pH 5–6; frozen aliquots [3][5][9] |
| N-terminal Gln | Cyclization to pyroglutamate | Occurs readily when Gln is N-terminal | Expect it; store dry and cold [5] |
| Asp-Pro | Peptide bond cleavage via cyclic imide | Acidic conditions | Avoid prolonged strong-acid exposure [5][9] |
Labeling and documentation
Good records make results reproducible and let you trace a problem back to a specific lot. For each vial and every aliquot derived from it:
- Record the product name, lot number and date received, and file the lot’s Certificate of Analysis (COA).
- Note the salt form and net peptide content from the COA, and the correction used for concentration calculations.
- Label aliquots with peptide name, lot number, concentration, solvent, preparation date and preparer’s initials, using freezer-safe labels.
- Log storage location, and each time an aliquot is thawed or used.
- Do not mix material from different lots in one stock solution.
Kalibra ships research peptides lyophilized in sealed vials, each labeled with its lot number and storage conditions (−20 °C, protect from light). You can browse the Kalibra catalog, and our guide on how to read a peptide Certificate of Analysis explains where to find purity, identity and lot data.
Frequently asked questions
Why let a vial warm up before opening it?
A cold vial opened in room air collects condensation. Lyophilized peptides are often hygroscopic, and absorbed water lowers effective peptide content and can reduce stability. Warming the sealed vial in a desiccator prevents this [1][2].
Is −20 °C cold enough for long-term storage?
For lyophilized peptides, −20 °C is a common storage temperature. Some suppliers prefer −80 °C for extended periods, especially for sequences containing Cys, Met, Trp, Asn or Gln [1][3][6].
Why does my calculated concentration seem high?
The weighed solid includes counter-ions and residual water, so net peptide content is often about 70–90% of gross weight. Correct your calculation with the lot’s reported net peptide content [2][8].
Can I dissolve a Cys- or Met-containing peptide in DMSO?
It is best avoided. Sigma-Aldrich notes that Cys- and Met-containing sequences are unstable in DMSO. For hydrophobic sequences that contain Cys or Met, other organic solvents listed for hydrophobic peptides, such as DMF or acetonitrile, are sometimes used instead [4].
References
- Bachem. Handling and Storage Guidelines for Peptides. bachem.com
- Bachem. Care and Handling of Peptides. 2021. bachem.com
- Sigma-Aldrich (Merck). Handling and Storage Guidelines for Peptides and Proteins. sigmaaldrich.com
- Sigma-Aldrich (Merck). Solubility Guidelines for Peptides. sigmaaldrich.com
- Sigma-Aldrich (Merck). Peptide Stability and Potential Degradation Pathways. sigmaaldrich.com
- Thermo Fisher Scientific. Custom Peptide Storage and Dissolution. thermofisher.com
- Sigma-Aldrich (Merck). Protein Binding in Sterile Filtration of Cell Culture Media. sigmaaldrich.com
- Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals. 2025;18:1163. doi:10.3390/ph18081163
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of Protein Pharmaceuticals: An Update. Pharmaceutical Research. 2010;27:544–575. doi:10.1007/s11095-009-0045-6
- Tang X, Pikal MJ. Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice. Pharmaceutical Research. 2004;21:191–200. doi:10.1023/B:PHAM.0000016234.73023.75
For Research Use Only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. This guide is general laboratory reference information.
